{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:05:42Z","timestamp":1757624742226,"version":"3.44.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019120","name":"Otsuka America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1053\/j.akdh.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T04:22:58Z","timestamp":1702354978000},"page":"417-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of Hypertension and Associated Cardiovascular Disease in Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1053","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8933-4880","authenticated-orcid":false,"given":"Frederic F.","family":"Rahbari-Oskoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.akdh.2023.03.004_bib1","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence Estimates of polycystic kidney and liver disease by population Sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic Complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib3","first-page":"806","article-title":"Analysis of causes of mortality in patients with autosomal dominant polycystic kidney disease: a single center study","volume":"20","author":"Rahman","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"7","key":"10.1053\/j.akdh.2023.03.004_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10157-022-02200-5","article-title":"Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective","volume":"26","author":"Abou Heidar","year":"2022","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2023.03.004_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurheartj\/ehy422","article-title":"Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis","volume":"40","author":"O\u2019Shaughnessy","year":"2019","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1053\/j.akdh.2023.03.004_bib6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCULATIONAHA.107.710111","article-title":"Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1","volume":"117","author":"Nauli","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2009.08.045","article-title":"Polycystin-1 and -2 dosage regulates pressure sensing","volume":"139","author":"Sharif-Naeini","year":"2009","journal-title":"Cell"},{"issue":"11","key":"10.1053\/j.akdh.2023.03.004_bib8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCULATIONAHA.118.034731","article-title":"Polycystin-1 Assembles with Kv channels to Govern cardiomyocyte repolarization and Contractility","volume":"140","author":"Altamirano","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1681\/ASN.V121194","article-title":"Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects","volume":"12","author":"Ecder","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/00365597409132130","article-title":"Hypertension in polycystic kidney disease","volume":"8","author":"Hansson","year":"1974","journal-title":"Scand J Urol Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2215\/CJN.11401017","article-title":"Prevalence of hypertension in children with early-stage ADPKD","volume":"13","author":"Massella","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib12","first-page":"566","article-title":"Fertility and pregnancy complications in women with autosomal dominant polycystic kidney disease","volume":"61","author":"Milutinovic","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1053\/j.akdh.2023.03.004_bib13","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease","volume":"8","author":"Chapman","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"24","key":"10.1053\/j.akdh.2023.03.004_bib14","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/ajkd.2001.29216","article-title":"Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1","volume":"38","author":"Lumiaho","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib16","first-page":"305","article-title":"Clinical presentation and outcome of autosomal dominant polycystic kidney disease in Pakistan: a single center experience","volume":"58","author":"Rabbani","year":"2008","journal-title":"J Pak Med Assoc"},{"issue":"14","key":"10.1053\/j.akdh.2023.03.004_bib17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM198810063191404","article-title":"Echocardiographic findings in autosomal dominant polycystic kidney disease","volume":"319","author":"Hossack","year":"1988","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib18","first-page":"211","article-title":"Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease","volume":"56","author":"Bardaji","year":"2001","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000343281","article-title":"Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease","volume":"36","author":"Helal","year":"2012","journal-title":"Am J Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2023.03.004_bib20","doi-asserted-by":"crossref","first-page":"19365","DOI":"10.18632\/oncotarget.14269","article-title":"An association between autosomal-dominant polycystic kidney disease and the risk of acute myocardial infarction in asian population - results of a nationwide study","volume":"8","author":"Sung","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib21","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1159\/000495638","article-title":"Clinical manifestation, management and Prognosis of acute myocardial infarction in autosomal dominant polycystic kidney disease","volume":"43","author":"Yang","year":"2018","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000522377","article-title":"Congenital heart disease in adults with autosomal dominant polycystic kidney disease","volume":"53","author":"Chedid","year":"2022","journal-title":"Am J Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2023.03.004_bib23","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2215\/CJN.14691218","article-title":"Presymptomatic screening for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease","volume":"14","author":"Sanchis","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2023.03.004_bib24","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/ndt\/gfac027","article-title":"Diagnosis and Risk Factors for Intracranial Aneurysms in Autosomal Polycystic Kidney Disease: A Cross-Sectional Study from the Genkyst Cohort","volume":"37","author":"Lefevre","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib25","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2215\/CJN.09731110","article-title":"Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease","volume":"6","author":"Irazabal","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.amjcard.2018.10.030","article-title":"Risk of Ascending aortic aneurysm in patients with autosomal dominant polycystic kidney disease","volume":"123","author":"Boulet","year":"2019","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00179997","article-title":"Aneurysms of coronary arteries in a patient with adult polycystic kidney disease: arteriosclerosis or involvement by the primary disease?","volume":"71","author":"Christ","year":"1993","journal-title":"Clin Investig"},{"issue":"10","key":"10.1053\/j.akdh.2023.03.004_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrneph.2015.128","article-title":"Vascular complications in autosomal dominant polycystic kidney disease","volume":"11","author":"Perrone","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/nep.12373","article-title":"Aortic dissection in patients with autosomal dominant polycystic kidney disease: a series of two cases and a review of the literature","volume":"20","author":"Silverio","year":"2015","journal-title":"Nephrology"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/0886022X.2016.1144209","article-title":"Autosomal dominant polycystic kidney disease and coronary artery dissection or aneurysm: a systematic review","volume":"38","author":"Neves","year":"2016","journal-title":"Ren Fail"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytz216","article-title":"Spontaneous coronary artery dissection in a patient with hereditary polycystic kidney disease and a recent liver transplant: a case report","volume":"3","author":"Verlaeckt","year":"2019","journal-title":"Eur Heart J Case Rep"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0272-6386(95)90629-0","article-title":"Spontaneous vertebral artery dissection as a complication of autosomal dominant polycystic kidney disease","volume":"25","author":"Larranaga","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib33","doi-asserted-by":"crossref","first-page":"e2623","DOI":"10.1097\/MD.0000000000002623","article-title":"New-onset atrial fibrillation is associated with polycystic kidney disease: a nationwide population-based cohort study","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"11","key":"10.1053\/j.akdh.2023.03.004_bib34","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/CIRCULATIONAHA.118.034075","article-title":"Mitral valve prolapse, ventricular arrhythmias, and sudden death","volume":"140","author":"Basso","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib35","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/jcm11041127","article-title":"Pericardial effusion on MRI in autosomal dominant polycystic kidney disease","volume":"11","author":"Liu","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib36","first-page":"332","article-title":"Compression of the inferior vena cava by right renal cysts: an unusual cause of IVC and\/or iliofemoral thrombosis with pulmonary embolism in autosomal dominant polycystic kidney disease","volume":"49","author":"O\u2019Sullivan","year":"1998","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib37","first-page":"75","article-title":"Massive inferior vena cava thrombosis in a patient with autosomal dominant polycystic hepatorenal disease","volume":"22","author":"Peces","year":"2002","journal-title":"Nefrologia"},{"issue":"11","key":"10.1053\/j.akdh.2023.03.004_bib38","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00007611-197911000-00013","article-title":"Obstruction of the inferior vena cava complicating hemodialysis in polycystic kidney disease","volume":"72","author":"Raulerson","year":"1979","journal-title":"South Med J"},{"issue":"42","key":"10.1053\/j.akdh.2023.03.004_bib39","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1055\/s-2008-1063792","article-title":"[Inferior vena cava compression syndrome in cystic kidney. Duplex ultrasonic diagnosis]","volume":"116","author":"Leimenstoll","year":"1991","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000185816","article-title":"Inferior vena caval compression by hepatic cysts: an unusual complication of adult polycystic kidney disease","volume":"54","author":"Yaqoob","year":"1990","journal-title":"Nephron"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5414\/CNP61344","article-title":"Vascular abnormalities in patients with autosomal dominant polycystic kidney disease--the influence on arteriovenous fistula creation","volume":"61","author":"Weyde","year":"2004","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib42","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1046\/j.1523-1755.2003.00264.x","article-title":"The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease","volume":"64","author":"Schrier","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1573402111309010002","article-title":"Cardiovascular complications in autosomal dominant polycystic kidney disease","volume":"9","author":"Ecder","year":"2013","journal-title":"Curr Hypertens Rev"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the consortium for Radiologic imaging studies of polycystic kidney disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00126097-200306000-00003","article-title":"Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease","volume":"8","author":"Seeman","year":"2003","journal-title":"Blood Press Monit"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MBP.0b013e328344c6f3","article-title":"Short-term reproducibility of ambulatory blood pressure monitoring in autosomal dominant polycystic kidney disease","volume":"16","author":"Rahbari-Oskoui","year":"2011","journal-title":"Blood Press Monit"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/01.CIR.88.3.986","article-title":"Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events","volume":"88","author":"Verdecchia","year":"1993","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.mbp.0000172706.51792.04","article-title":"Association of blunted nocturnal blood pressure dip with intracerebral hemorrhage","volume":"10","author":"Tsivgoulis","year":"2005","journal-title":"Blood Press Monit"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.HYP.0000198541.12640.0f","article-title":"Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study","volume":"47","author":"Metoki","year":"2006","journal-title":"Hypertension"},{"issue":"24","key":"10.1053\/j.akdh.2023.03.004_bib50","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1001\/jama.295.24.2859","article-title":"Diurnal blood pressure pattern and risk of congestive heart failure","volume":"295","author":"Ingelsson","year":"2006","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.akdh.2023.03.004_bib51","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3109\/07420528.2010.510230","article-title":"Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study","volume":"27","author":"Hermida","year":"2010","journal-title":"Chronobiol Int"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib52","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ki.1988.115","article-title":"The anatomy of the renin-secreting cell in adult polycystic kidney disease","volume":"33","author":"Graham","year":"1988","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ki.1992.297","article-title":"Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease","volume":"42","author":"Torres","year":"1992","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib54","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.ASN.0000109782.28991.26","article-title":"Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease","volume":"15","author":"McPherson","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000013382","article-title":"Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives","volume":"18","author":"Cerasola","year":"1998","journal-title":"Am J Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2023.03.004_bib56","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1681\/ASN.V12112427","article-title":"Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension","volume":"12","author":"Klein","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"10.1053\/j.akdh.2023.03.004_bib57","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","article-title":"The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease","volume":"323","author":"Chapman","year":"1990","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib58","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.akdh.2023.03.004_bib59","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.3390\/s90907003","article-title":"Primary cilia: highly sophisticated biological sensors","volume":"9","author":"Abou Alaiwi","year":"2009","journal-title":"Sensors"},{"key":"10.1053\/j.akdh.2023.03.004_bib60","doi-asserted-by":"crossref","first-page":"e74765","DOI":"10.7554\/eLife.74765","article-title":"A plasma membrane-localized polycystin-1\/polycystin-2 complex in endothelial cells elicits vasodilation","volume":"11","author":"MacKay","year":"2022","journal-title":"Elife"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ndt\/gfw013","article-title":"Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease","volume":"32","author":"Nowak","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ackd.2010.01.001","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"17","author":"Chapman","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000166929","article-title":"Hypertension of polycystic kidney disease: mechanisms and hemodynamic alterations","volume":"5","author":"Valvo","year":"1985","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib64","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.hjh.0000222765.30348.0d","article-title":"The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients","volume":"24","author":"Doulton","year":"2006","journal-title":"J Hypertens"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib65","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000354317","article-title":"A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease","volume":"38","author":"Kocyigit","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.akdh.2023.03.004_bib66","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12882-015-0075-8","article-title":"Increased urinary Angiotensinogen\/Creatinine (AGT\/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients","volume":"16","author":"Park","year":"2015","journal-title":"BMC Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2023.03.004_bib67","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ndt\/7.7.647","article-title":"Autosomal dominant polycystic kidney-disease with primary hyperaldosteronism","volume":"7","author":"Bobrie","year":"1992","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1053\/j.akdh.2023.03.004_bib68","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0248-8663(05)82186-1","article-title":"Association of autosomal polycystic kidney-disease and primary hyperaldosteronism","volume":"15","author":"Oziol","year":"1994","journal-title":"Revue De Medecine Interne"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib69","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ndt\/12.3.591","article-title":"Unsuspected atherosclerotic renal artery stenosis causing renal failure in a patient with adult polycystic kidney disease","volume":"12","author":"Makanjuola","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.akdh.2023.03.004_bib70","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/archinte.1978.03630330080024","article-title":"Renal artery stenosis and polycystic kidney disease","volume":"138","author":"Messerli","year":"1978","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib71","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2215\/CJN.04310709","article-title":"The HALT polycystic kidney disease trials: design and implementation","volume":"5","author":"Chapman","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2023.03.004_bib72","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/01.ASN.0000018407.60002.B9","article-title":"Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study","volume":"13","author":"Schrier","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2023.03.004_bib73","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Kidney disease: improving global outcomes chronic kidney disease guideline development Work group, Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib74","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.kint.2016.10.018","article-title":"Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease","volume":"91","author":"Torres","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib75","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.kint.2020.04.053","article-title":"Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease","volume":"98","author":"Kramers","year":"2020","journal-title":"Kidney Int"},{"issue":"24","key":"10.1053\/j.akdh.2023.03.004_bib76","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","volume":"371","author":"Torres","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib77","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000046231","article-title":"Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease","volume":"21","author":"Ecder","year":"2001","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/oxfordjournals.qjmed.a030139","article-title":"Calcium channel blockers versus ACE inhibitors as antihypertensives in polycystic kidney disease","volume":"89","author":"Kanno","year":"1996","journal-title":"QJM"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib79","doi-asserted-by":"crossref","first-page":"c18","DOI":"10.1159\/000081790","article-title":"Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease","volume":"99","author":"Nutahara","year":"2005","journal-title":"Nephron Clin Pract"},{"issue":"12","key":"10.1053\/j.akdh.2023.03.004_bib80","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/ndt\/gft513","article-title":"Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease","volume":"29","author":"Rahbari-Oskoui","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.akdh.2023.03.004_bib81","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.ki.5001835","article-title":"Beta blockers in the management of chronic kidney disease","volume":"70","author":"Bakris","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib82","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.ki.5002629","article-title":"Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy\/+ rat","volume":"73","author":"Nagao","year":"2008","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib83","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0272-6386(00)70195-8","article-title":"Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease","volume":"35","author":"Ecder","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib84","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10157-010-0329-5","article-title":"Clinical effects of calcium channel blockers and renin-angiotensin-aldosterone system inhibitors on changes in the estimated glomerular filtration rate in patients with polycystic kidney disease","volume":"14","author":"Mitobe","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1053\/j.akdh.2023.03.004_bib85","first-page":"103","article-title":"Chronic kidney disease and pregnancy","volume":"15","author":"Jungers","year":"1986","journal-title":"Adv Nephrol Necker Hosp"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib86","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review","volume":"60","author":"Bullo","year":"2012","journal-title":"Hypertension"},{"issue":"23","key":"10.1053\/j.akdh.2023.03.004_bib87","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/17512433.2015.1005074","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits","volume":"8","author":"Pucci","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"11","key":"10.1053\/j.akdh.2023.03.004_bib89","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/HJH.0000000000001456","article-title":"In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review","volume":"35","author":"Fitton","year":"2017","journal-title":"J Hypertens"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib90","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1081\/PRG-120002912","article-title":"Excretion of antihypertensive medication into human breast milk: a systematic review","volume":"21","author":"Beardmore","year":"2002","journal-title":"Hypertens Pregnancy"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib92","first-page":"414","article-title":"Spontaneous coronary artery dissection: one more extrarenal manifestation of autosomal dominant polycystic kidney disease?","volume":"22","author":"Basile","year":"2009","journal-title":"J Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib93","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjcard.2018.10.012","article-title":"Conditions and factors associated with Spontaneous coronary artery dissection (from a national population-based cohort study)","volume":"123","author":"Krittanawong","year":"2019","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib94","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.arcmed.2005.07.009","article-title":"Autosomal dominant polycystic kidney disease reduces the risk of diabetes mellitus","volume":"37","author":"Pietrzak-Nowacka","year":"2006","journal-title":"Arch Med Res"},{"key":"10.1053\/j.akdh.2023.03.004_bib95","series-title":"autosomal dominant polycystic kidney disease","first-page":"1","article-title":"The Pathophysiology of left ventricular hypertrophy, beyond hypertension","author":"Oto","year":"2022"},{"issue":"10","key":"10.1053\/j.akdh.2023.03.004_bib96","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.2215\/CJN.04610511","article-title":"Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease","volume":"6","author":"Perrone","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib97","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/ndt\/14.5.1113","article-title":"Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease","volume":"14","author":"Ecder","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib98","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ekir.2017.05.014","article-title":"Autosomal dominant polycystic kidney patients may Be predisposed to various cardiomyopathies","volume":"2","author":"Chebib","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib99","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12882-019-1555-z","article-title":"Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients","volume":"20","author":"Chen","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.akdh.2023.03.004_bib100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijcard.2018.10.063","article-title":"Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: a cross-sectional and longitudinal substudy of the ALADIN trial","volume":"275","author":"Spinelli","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.akdh.2023.03.004_bib101","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.dib.2018.11.041","article-title":"Data on the assessment of LV mechanics by speckle tracking echocardiography in ADPKD patients","volume":"21","author":"Spinelli","year":"2018","journal-title":"Data Brief"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib102","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2215\/CJN.01920507","article-title":"Increased occurrence of pericardial effusion in patients with autosomal dominant polycystic kidney disease","volume":"2","author":"Qian","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"493","key":"10.1053\/j.akdh.2023.03.004_bib103","doi-asserted-by":"crossref","first-page":"eaax0290","DOI":"10.1126\/scitranslmed.aax0290","article-title":"Primary cilia defects causing mitral valve prolapse","volume":"11","author":"Toomer","year":"2019","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1053\/j.akdh.2023.03.004_bib104","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ng.3383","article-title":"Genetic association analyses highlight biological pathways underlying mitral valve prolapse","volume":"47","author":"Dina","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2046-2530-2-7","article-title":"The SYSCILIA gold standard (SCGSv1) of known ciliary components and its applications within a systems biology consortium","volume":"2","author":"van Dam","year":"2013","journal-title":"Cilia"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib106","first-page":"245","article-title":"The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: a 10-year follow-up in a five-generation kindred","volume":"37","author":"Timio","year":"1992","journal-title":"Clin Nephrol"},{"issue":"20","key":"10.1053\/j.akdh.2023.03.004_bib107","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.3390\/jcm11205982","article-title":"Echocardiographic abnormalities in autosomal dominant polycystic kidney disease (ADPKD) patients","volume":"11","author":"Pfeferman","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib108","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ki.1991.238","article-title":"Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease","volume":"40","author":"Harrap","year":"1991","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.akdh.2023.03.004_bib109","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1681\/ASN.V5122032","article-title":"Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease","volume":"5","author":"Ivy","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib110","doi-asserted-by":"crossref","first-page":"e018971","DOI":"10.1161\/JAHA.120.018971","article-title":"Outcomes of surgical mitral and aortic valve replacements among kidney transplant Candidates: Implications for valve selection","volume":"10","author":"Ngendahimana","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib111","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1523-1755.2005.67132.x","article-title":"Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation","volume":"67","author":"de Mattos","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib112","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2021.06.013","article-title":"Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)","volume":"100","author":"Perrone","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2023.03.004_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125603","article-title":"Effect of sodium-glucose Cotransport inhibition on polycystic kidney disease progression in PCK rats","volume":"10","author":"Kapoor","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib114","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1159\/000368540","article-title":"Inhibition of sodium-glucose Cotransporter 2 with Dapagliflozin in han: SPRD rats with polycystic kidney disease","volume":"40","author":"Rodriguez","year":"2015","journal-title":"Kidney Blood Press Res"},{"issue":"16","key":"10.1053\/j.akdh.2023.03.004_bib115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2022.4983","article-title":"Aspirin Use to prevent cardiovascular disease: US preventive services task force recommendation statement","volume":"327","author":"Force","year":"2022","journal-title":"JAMA"},{"key":"10.1053\/j.akdh.2023.03.004_bib116","first-page":"19","article-title":"Cyclooxygenase product inhibition with acetylsalicylic acid slows disease progression in the Han:SPRD-Cy rat model of polycystic kidney disease, Prostaglandins Other Lipid","volume":"116-117","author":"Ibrahim","year":"2015","journal-title":"Mediat"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib117","first-page":"1","article-title":"Aspirin associated with decreased rate of intracranial aneurysm growth","volume":"133","author":"Zanaty","year":"2019","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib118","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"Kidney disease: Improving global outcomes Lipid guideline development Work group, KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"issue":"16","key":"10.1053\/j.akdh.2023.03.004_bib119","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2010.09.082","volume":"57","author":"Hsia","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib120","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.08350813","article-title":"Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease","volume":"9","author":"Cadnapaphornchai","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib121","first-page":"109","article-title":"Effect of statin therapy on the progression of autosomal dominant polycystic kidney disease. A secondary analysis of the HALT PKD trials","volume":"13","author":"Brosnahan","year":"2017","journal-title":"Curr Hypertens Rev"},{"issue":"5","key":"10.1053\/j.akdh.2023.03.004_bib122","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/01.STR.32.5.1173","article-title":"Attributable risk of common and rare determinants of subarachnoid hemorrhage","volume":"32","author":"Ruigrok","year":"2001","journal-title":"Stroke"},{"issue":"6","key":"10.1053\/j.akdh.2023.03.004_bib123","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.V561349","article-title":"Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease","volume":"5","author":"Chapman","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib124","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1046\/j.1523-1755.1998.00067.x","article-title":"Smoking as a risk factor for end-stage renal failure in men with primary renal disease","volume":"54","author":"Orth","year":"1998","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.hjh.0000199800.72563.26","article-title":"Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials","volume":"24","author":"Dickinson","year":"2006","journal-title":"J Hypertens"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib126","doi-asserted-by":"crossref","first-page":"F35","DOI":"10.1152\/ajprenal.00282.2019","article-title":"Dietary phosphate restriction attenuates polycystic kidney disease in mice","volume":"318","author":"Omede","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"10.1053\/j.akdh.2023.03.004_bib127","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1172\/JCI128503","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"129","author":"Torres","year":"2019","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.akdh.2023.03.004_bib128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic kidney disease-Mineral and Bone disorder (CKD-MBD) guideline Update: what\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2023.03.004_bib129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.kint.2015.12.002","article-title":"Body mass index and causes of death in chronic kidney disease","volume":"89","author":"Navaneethan","year":"2016","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2023.03.004_bib130","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1681\/ASN.2017070819","article-title":"Overweight and obesity are Predictors of progression in early autosomal dominant polycystic kidney disease","volume":"29","author":"Nowak","year":"2018","journal-title":"J Am Soc Nephrol"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294981392300037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294981392300037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:40:13Z","timestamp":1757432413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294981392300037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":129,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S294981392300037X"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2023.03.004","relation":{},"ISSN":["2949-8139"],"issn-type":[{"type":"print","value":"2949-8139"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Hypertension and Associated Cardiovascular Disease in Autosomal Dominant Polycystic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}